According to Zhitong Finance App, Nongshim Technology (001231.SZ) announced that the company's wholly-owned subsidiary, Shaanxi Shanggezhilu Bioscience Co., Ltd. (hereinafter referred to as “Shangge Road”), increased the capital of its holding subsidiary Shaanxi Yijianyi Bioengineering Co., Ltd. (hereinafter referred to as “One Simple One to”) with its own or self-funded capital of 141.3 million yuan. Following the completion of this capital increase, the registered capital from RMB150 million to RMB300 million will be increased from RMB150 million to RMB300 million.

The aim of this time is to increase the capital of its holding subsidiary one by one. The aim is to provide more financial support for its business development and daily operations, which is conducive to optimizing its capital structure, reducing its balance to liability ratio, and further enhancing its capital strength, which is in line with the company's overall development strategy.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.